首页> 美国卫生研究院文献>Obstetrics Gynecology Science >Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer

【2h】

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer

机译：依托泊苷联合异环磷酰胺联合化疗对重度复发或持续性上皮性卵巢癌患者的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThis retrospective study is to evaluate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of pretreated recurrent or persistent epithelial ovarian cancer (EOC).

机译：目的这项回顾性研究旨在评估依托泊苷和异环磷酰胺（ETI）联合化疗在治疗复发性或持续性上皮性卵巢癌（EOC）中的疗效和毒性。

著录项

期刊名称 Obstetrics Gynecology Science
作者
Wonkyo Shin; Hye-joo Lee; Seong J. Yang; E sun Paik; Hyun-jin Choi; Tae-Joong Kim; Chel Hun Choi; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim;
展开▼
作者单位

展开▼
年(卷),期 2018(61),3
年度 2018
页码 352–358
总页数 7
原文格式 PDF
正文语种
中图分类妇产科学;
关键词
Ovarian cancer Recurrence Platinum-free interval;

机译：卵巢癌;复发;无铂间隔;

相似文献

外文文献
中文文献
专利

1. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer [J] . Kang Heeseok, Kim Tae-Joong, Choi Chel Hun, Journal of Korean medical science. . 2009,第5期

机译：重度复发或持续性上皮性卵巢癌患者联合依托泊苷和异环磷酰胺联合化疗的II期研究
2. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis [J] . Choi Hyun-Jin, Paik E. Sun, Choi Chel Hun, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2018,第7期

机译：对紫杉醇/ IFOSFAMIDE /铂与紫杉醇/铂的组合化疗的反应，用于患有子宫子宫颈的转移性，复发或持续癌的患者回顾性分析
3. Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study [J] . Qi Huang, Chaonan Chu, Jie Tang, Journal of Cancer . 2020,第18期

机译：磷钛与依托泊苷中的疗效和安全性在复发性铂抗性上皮癌症患者中的疗效和安全性：回顾性研究
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer [O] . Heeseok Kang, Tae-Joong Kim, Chel Hun Choi, 2009

机译：重度复发或持续性上皮性卵巢癌患者联合依托泊苷和异环磷酰胺联合化疗的II期研究
7. RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH ETOPOSIDE AND IFOSFAMIDE IN PATIENTS WITH HEAVILY PRETREATED RECURRENT OR PERSISTENT EPITHELIAL OVARIAN CANCER [O] . Shin Wonkyo 2017

机译：依托皂苷和二聚石组合化疗的回顾性研究患有重预处理复发性或持续上皮卵巢癌的患者

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer

摘要

著录项

相似文献

相关主题

期刊订阅